Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Autosomal recessive CD81 deficiency has been reported in two unrelated patients with biallelic loss-of-function variants leading to common variable immunodeficiency (CVID). The first case harbored a homozygous splice-site mutation resulting in intracellularly retained truncated CD81 protein and complete absence of CD19 surface expression on B cells ([PMID:25739915]). The second patient carried novel biallelic CD81 mutations that abolished surface CD81, led to IgA nephropathy, profound hypogammaglobulinemia, reduced switched memory and transitional B cells, and impaired BCR signaling ([PMID:35849269]). Multi-gene panel studies in CVID cohorts detected CD81 variants in <15% of cases but without clear pathogenicity, underscoring genetic heterogeneity ([PMID:21905497]; [PMID:33859323]).
Functional analyses demonstrate that truncated CD81 fails to traffic CD19 to the cell surface, preventing normal BCR assembly and signaling. Patient B cells show reduced phosphorylation of key BCR signaling molecules (pY, pBTK) and downregulation of immunoglobulin gene expression, consistent with haploinsufficiency of CD81 in B-cell development. These concordant genetic and experimental data support a causal role for autosomal recessive CD81 deficiency in CVID, although current evidence is limited to two families. Key Take-home: CD81 testing should be considered in CVID patients with absent CD19 expression and unexplained hypogammaglobulinemia.
Gene–Disease AssociationLimited2 unrelated probands ([PMID:25739915]; [PMID:35849269]) with biallelic CD81 mutations and segregation consistent with autosomal recessive inheritance Genetic EvidenceLimitedTwo families with biallelic loss-of-function CD81 variants and consistent AR segregation Functional EvidenceModerateTruncating CD81 mutations impair CD19 trafficking, BCR signaling and Ig production in patient B cells |